Show simple item record

dc.contributor.authorStubbs, Men
dc.contributor.authorBiswas, Sen
dc.contributor.authorTroy, Hen
dc.contributor.authorLeek, Ren
dc.contributor.authorChung, YLen
dc.contributor.authorLi, JLen
dc.contributor.authorRaval, RRen
dc.contributor.authorTurley, Hen
dc.contributor.authorGatter, Ken
dc.contributor.authorPezzella, Fen
dc.contributor.authorGriffiths, JRen
dc.contributor.authorHarris, ALen
dc.date.accessioned2017-11-27T16:45:22Z
dc.date.available2017-11-27T16:45:22Z
dc.date.issued2010-08-13en
dc.identifier.issn1687-8450en
dc.identifier.urihttp://hdl.handle.net/10026.1/10311
dc.description.abstract

In cultured clear-cell renal carcinoma (CCRCC) 786-0 cells transfected with HIF1 (HIF-1+), HIF-2 (HIF-2+), or empty vector (EV), no significant differences were observed in the growth rates in vitro, but when grown in vivo as xenografts HIF-2 significantly increased, and HIF-1 significantly decreased growth rates, compared to EV tumors. Factors associated with proliferation were increased and factors associated with cell death were decreased in HIF-2+ tumors. Metabolite profiles showed higher glucose and lower lactate and alanine levels in the HIF-2+ tumors whilst immunostaining demonstrated higher pyruvate dehydrogenase and lower pyruvate dehydrogenase kinase 1, compared to control tumors. Taken together, these results suggest that overexpression of HIF-2 in CCRCC 786-0 tumors regulated growth both by maintaining a low level of glycolysis and by allowing more mitochondrial metabolism and tolerance to ROS induced DNA damage. The growth profiles observed may be mediated by adaptive changes to a more oxidative phenotype. Copyright © 2010 Swethajit Biswas et al.

en
dc.language.isoenen
dc.titleEffects of HIF-1 and HIF2 on growth and metabolism of clear-cell renal cell carcinoma 786-0 xenograftsen
dc.typeJournal Article
plymouth.publication-statusPublisheden
plymouth.journalJournal of Oncologyen
dc.identifier.doi10.1155/2010/757908en
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/00 Groups by role
plymouth.organisational-group/Plymouth/00 Groups by role/Academics
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/Biomedical Research Group
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/Biomedical Research Group/RC Reporting Group BRG
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/Collaboration for the Advancement of Medical Education Research Assessment
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
dc.identifier.eissn1687-8469en
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.1155/2010/757908en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV